" /> Belinostat - CISMeF





Preferred Label : Belinostat;

NCIt related terms : PXD 101; PXD101;

NCIt definition : A novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity. Belinostat targets HDAC enzymes, thereby inhibiting tumor cell proliferation, inducing apoptosis, promoting cellular differentiation, and inhibiting angiogenesis. This agent may sensitize drug-resistant tumor cells to other antineoplastic agents, possibly through a mechanism involving the down-regulation of thymidylate synthase.;

Alternative definition : NCI-GLOSS: A substance being studied in the treatment of cancer. Belinostat blocks enzymes needed for cell division and may kill cancer cells. It also prevents the growth of blood vessels needed for tumors to grow and may make tumor cells more sensitive to other anticancer drugs. It is a type of histone deacetylase (HDAC) inhibitor, a type of angiogenesis inhibitor, and a type of chemosensitizer.;

UNII : F4H96P17NZ;

InChIKey : NCNRHFGMJRPRSK-MDZDMXLPSA-N;

CAS number : 414864-00-9; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 414864-00-9 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Beleodaq;

Molecule name : PXD 101; PXD101;

Chemical formula : C15H14N2O4S;

NSC code : 726630;

ChEBI ID : CHEBI:61076;

Codes from synonyms : CDR0000486423; CDR0000600484; 32043; 63;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.